background
viral
myocard
vmc
treatment
long
lack
effect
method
former
studi
indic
role
calpain
vmc
pathogenesi
studi
aim
verifi
potenti
calpain
coxsackieviru
induc
myocard
treatment
method
transgen
mous
overexpress
endogen
calpain
inhibitor
calpastatin
introduc
studi
vmc
mous
model
establish
via
intraperiton
inject
transgen
wild
mous
respect
myocardi
injuri
assay
histolog
stain
patholog
grade
serolog
myocardi
damag
marker
ckmb
ctni
replic
observ
vivo
vitro
via
capsid
protein
detect
viru
titrat
inflammationfibrot
factor
mpo
perforin
evalu
use
western
blot
immunohistolog
stain
role
calpain
regul
fibroblast
migrat
studi
scratch
assay
result
calpastatin
overexpress
amelior
myocardi
injuri
induc
infect
significantli
transgen
mous
indic
reduc
peripher
ckmb
ctni
level
improv
histolog
injuri
compar
wild
type
mous
transgen
mous
heart
tissu
carri
lower
viru
load
inflamm
factor
mpo
perforin
downregul
accompani
fibrot
agent
inhibit
calpain
particip
migrat
fibroblast
vitro
prove
role
regul
fibrosi
conclus
calpain
play
dual
role
facilit
replic
inflamm
promot
calpain
inhibit
myocard
show
signific
treatment
effect
calpain
might
novel
target
vmc
treatment
clinic
practic
viral
myocard
vmc
common
cardiovascular
diseas
clinic
practic
mani
vmc
case
show
selflimit
regress
still
approxim
case
progress
dilat
cardiomyopathi
dcm
heart
failur
might
requir
mechan
circulatori
support
heart
transplant
end
stage
despit
optim
pharmacotherapi
effect
treatment
vmc
earli
stage
meaning
vmc
treatment
alway
challeng
especi
regard
immunosuppress
treatment
mani
research
consid
vmc
autoimmun
diseas
made
immunosuppress
treatment
reason
howev
viru
persist
myocardium
hold
back
intend
host
immun
suppress
might
enhanc
viru
replic
clinic
observ
myocard
immunosuppress
therapi
also
return
controversi
result
guidelin
also
weight
word
issu
ambigu
might
attribut
sever
reason
core
concern
might
risk
prescrib
immunosuppress
agent
consid
role
host
immun
respons
viru
clearanc
besid
nt
complet
clarifi
life
cycl
intrudedvirus
nt
know
time
interfer
diseas
cours
pattern
virus
interact
host
basic
vagu
nt
know
appropri
method
interfer
last
least
myocarditiscaus
virus
spectrum
alway
shift
tempor
region
add
anoth
variabl
clinic
specialist
face
uniqu
patient
suffer
vmc
thu
logic
speak
candid
compromis
two
factor
viru
replic
host
inflamm
respons
might
optim
choic
found
former
studi
calpain
famili
neutral
cystein
proteas
could
facilit
coxsackieviru
common
caus
viru
vmc
replic
vitro
besid
mani
studi
demonstr
calpain
mediat
system
inflamm
respons
vivo
calpain
might
particip
viru
life
cycl
host
inflamm
respons
simultan
case
calpain
would
optic
choic
myocard
treatment
calpain
activ
regul
endogen
inhibitor
calpastatin
calpastatin
intracellular
protein
inhibit
calpain
activ
specif
bind
calpastatin
across
calpain
activ
site
would
block
access
substrat
vivo
howev
calpastatin
could
penetr
across
cell
membran
larg
molecular
weight
use
inhibitor
vitro
thu
introduc
transgen
mous
overexpress
calpastatin
vivo
discuss
hypothesi
mous
model
viral
myocard
coxsackieviru
nanci
strain
preserv
key
laboratori
viral
heart
diseas
zhongshan
hospit
fudan
univers
calpain
inhibitor
nacetylleuleunorleucin
alln
inhibitor
neutral
cystein
proteas
purchas
commerci
biomol
research
laboratori
inc
usa
catalog
dissolv
dimethyl
sulfoxid
dmso
amresco
llc
usa
product
code
final
concentr
less
cell
cultur
studi
alln
dilut
use
cultur
medium
target
concentr
research
calpastatin
transgen
mous
strain
tgcast
introduc
laboratori
tianq
peng
lawson
health
research
institut
canada
bred
depart
laboratori
anim
scienc
fudan
univers
standard
specif
pathogen
free
spf
environ
male
inbr
mice
week
use
experi
group
wild
type
control
group
con
n
transgen
mous
control
group
tgcast
n
group
viru
n
transgen
mous
group
viru
tgcast
n
litterm
genotyp
follow
protocol
peng
lab
give
assur
anim
receiv
human
care
studi
protocol
approv
ethic
committe
fudan
univers
viral
myocard
model
establish
follow
protocol
sd
previou
short
tcid
ml
ml
inject
intraperiton
amount
pb
control
mice
kept
spf
environ
day
sacrific
occasion
dead
mous
exclud
studi
blood
sampl
collect
via
pick
eye
ball
serum
separ
via
centrifug
rmin
min
method
grade
standard
prescrib
elsewher
level
peripher
ctni
ckmb
measur
elisa
assay
follow
protocol
former
studi
heart
tissu
grin
use
homogen
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
glycerol
contain
proteas
inhibitor
cocktail
ice
tissu
homogen
centrifug
g
min
protein
concentr
determin
bradford
assay
biorad
detail
western
blot
protocol
describ
elsewher
former
studi
brief
equal
amount
protein
load
sd
gel
electrophoresi
transfer
nitrocellulos
membran
block
blot
incub
overnight
primari
antibodi
bioworld
technolog
inc
usa
catalog
respect
follow
incub
anoth
hour
correspond
secondari
antibodi
band
visual
ecl
super
signal
west
pico
kit
pierc
quantifi
densitometri
use
quantiti
one
softwar
biorad
gapdh
use
intern
refer
viru
titer
measur
use
tcid
assay
hela
cell
heart
tissu
homogen
prepar
use
ice
cold
homogen
follow
centrifug
harvest
viruscontain
supernat
decim
serial
dilut
cell
cultur
supernat
tissu
homogen
supernat
ad
cultur
hela
cell
incub
h
infect
hela
cell
cultur
cytopath
effect
observ
daili
day
tcid
calcul
use
reedmuench
method
mmp
activ
detect
accord
instruct
commerci
assay
kit
anaspec
inc
ca
catalog
tissu
homogen
assay
buffer
centrifug
min
g
follow
incub
apma
final
concentr
mm
assay
buffer
h
activ
mmp
immedi
experi
dilut
substrat
assay
buffer
add
per
well
sampl
substrat
solut
plate
mix
reagent
shake
plate
gentli
incub
reaction
min
keep
plate
away
direct
light
add
pe
well
stop
solut
mix
reagent
measur
fluoresc
intens
exem
nm
plot
data
rfu
fold
chang
compar
control
immunohistochemistri
stain
leica
biosystem
newcastl
ltd
unit
kingdom
catalog
nclentero
bio
legend
inc
usa
catalog
abcam
inc
usa
catalog
carri
accord
method
prescrib
elsewher
mpo
activ
assay
use
commerci
kit
sigmaaldrich
co
llc
usa
catalog
standard
curv
prepar
accord
instruct
tissu
sampl
mg
heart
tissu
volum
mpo
assay
buffer
prepar
use
mpo
assay
buffer
follow
make
master
reaction
mix
room
temperatur
fluoresc
intens
read
mpo
activ
calcul
accord
instruct
primari
cardiomyocyt
separ
neonat
rat
heart
short
neonat
rat
day
old
suppli
depart
laboratori
anim
scienc
fudan
univers
fertil
heart
taken
quickli
slice
piec
digest
trypsin
min
centrifug
rmin
collect
digest
cell
suspend
cell
dmem
repeat
digestcentrifug
cycl
left
tissu
becom
appar
collect
cell
suspend
dmem
contain
fb
cultur
h
adher
cell
fibroblast
still
suspend
cell
primari
cardiomyocyt
cardiomyocyt
count
seed
research
fibroblast
passag
routin
third
gener
cell
use
studi
prepar
cardiomyocyt
fast
dmem
overnight
follow
inocul
h
supernat
chang
dmem
contain
fb
cultur
design
time
cours
fibroblast
seed
plate
densiti
cellswel
cultur
h
cell
synchron
fast
dmem
without
fb
h
scratch
injuri
made
use
tip
pipet
dmem
contain
fb
chang
without
calpain
inhibitor
alln
biomol
research
laboratori
inc
usa
catalog
cultur
anoth
h
pictur
scratch
trace
taken
distanc
measur
analyz
data
specifi
mean
valu
sd
analyz
use
spss
softwar
version
spss
inc
chicago
il
usa
comparison
perform
use
student
test
p
b
consid
statist
signific
transgen
mous
lower
mortal
post
challeng
fig
calpain
inhibit
decreas
hwbw
ratio
significantli
fig
myocardi
damag
marker
ckmb
ctni
also
decreas
fig
peripher
blood
indic
protect
effect
calpastatin
overexpress
make
certain
calpain
activ
transgen
mous
degrad
product
calpainspecif
substrat
blot
expect
calpain
activ
downregul
transgen
mous
heart
tissu
fig
observ
role
calpain
activ
replic
capsid
protein
blot
show
compar
wild
type
mous
transgen
mous
lower
level
express
myocardium
fig
detect
immun
histolog
method
also
show
viru
capsid
protein
decreas
significantli
fig
viru
load
heart
tissu
titrat
demonstr
viru
titer
lower
heart
transgen
mous
fig
verifi
find
vitro
neonat
rat
cardiomyocyt
separ
accordingli
post
viru
infect
cell
inocul
cultur
medium
contain
calpain
inhibitor
alln
variou
dilut
respect
cardiomyocyt
inocul
cultur
medium
without
alln
set
normal
control
h
later
viru
load
supernat
titrat
found
compar
normal
control
alln
hinder
viru
replic
significantli
fig
observ
effect
calpastatin
overexpress
myocardi
inflamm
tissu
section
stain
compar
wild
litterm
inflamm
infiltr
transgen
mous
heart
tissu
amelior
significantli
fig
mpo
marker
neutrophil
infiltr
also
decreas
transgen
mous
heart
fig
perforin
effect
protein
cytotox
lymphocyt
natur
killer
transgen
mous
heart
calpain
inhibit
accompani
signific
perforin
downregul
post
viru
infect
fig
also
case
inflamm
factor
fig
fig
demonstr
role
calpain
mediat
inflamm
infiltr
virusinduc
myocard
fibrosi
key
pathophysiolog
cours
myocard
progress
thu
observ
whether
calpain
particip
fibrosi
myocard
classic
fibrot
agent
fig
fig
blot
demonstr
calpain
inhibit
result
downregul
two
factor
well
total
mmp
activ
fig
observ
calpain
could
regul
myocardi
fibroblast
function
proceed
scratch
assay
fibroblast
cultur
fibroblast
incub
calpain
inhibitor
alln
h
studi
util
calpastatinoverexpress
transgen
mous
model
viral
myocard
demonstr
endogen
calpain
inhibit
amelior
myocardi
injuri
significantli
simultan
calpain
inhibit
associ
decreas
replic
amelior
inflammationfibrosi
format
data
indic
dual
involv
calpain
viru
replic
host
inflamm
might
answer
ambigu
problem
immunosuppress
therapi
viral
myocard
treatment
calpain
famili
proteinas
cleav
substrat
peptid
segment
activ
regul
endogen
inhibitor
calpastatin
demonstr
transgen
mous
calpain
involv
myocardium
fibrosi
b
western
blot
respect
n
group
p
b
vs
con
group
p
b
vs
viru
group
c
heart
tissu
total
mmp
activ
assay
con
group
mmp
activ
set
arbitrarili
p
b
vs
con
group
p
b
vs
viru
group
n
group
repres
scratch
assay
pictur
cultur
fibroblast
without
calpain
inhibitor
alln
longer
distanc
indic
weaker
migrat
abil
cell
p
b
vs
con
group
experi
repeat
time
overexpress
calpastatin
lower
level
calpain
activ
vivo
fig
mani
research
report
involv
calpain
virus
life
cycl
exampl
calpain
particip
replic
influenza
viru
sever
acut
respiratori
syndrom
coronaviru
echoviru
human
immunodefici
viru
former
studi
found
calpain
activ
facilit
progeni
viru
replic
earli
phase
infect
vitro
bozym
et
al
report
role
calpain
mediat
cvb
entri
releas
endotheli
cell
yoon
et
al
demonstr
use
autophagi
replic
calpain
activ
rat
primari
neuron
present
paper
calpain
inhibit
reduc
load
vivo
vitro
fig
prove
calpain
involv
facilit
replic
role
calpain
regul
inflamm
observ
differ
anim
model
allerg
encephalomyel
sepsi
abdomin
aortic
atherosclerosi
ventilatorinduc
lung
injuri
hypercholesterolem
nephropathi
realm
viral
myocard
debiasi
et
al
found
mice
model
reoviru
strain
myocard
calpain
inhibit
protect
virusinduc
apoptot
myocardi
injuri
present
role
calpain
treat
myocard
evid
inflamm
mention
present
transgen
mous
mechan
calpain
involv
inflamm
might
associ
regul
inflamm
cell
behavior
point
support
evid
sever
studi
focus
differ
inflamm
cell
neutrophil
calpain
particip
cell
migrat
adhes
arrest
oxid
burst
also
contribut
igemedi
mast
cell
activ
calpastatin
overexpress
impair
post
infarct
scar
heal
mice
compromis
repar
immun
cell
recruit
activ
leukocyt
calpain
defici
reduc
angiotensin
iiinduc
inflamm
atherosclerosi
present
myocard
model
myocardium
inflamm
infiltr
significantli
amelior
transgen
mous
well
inflamm
factor
mpo
activ
perforin
although
might
background
level
express
factor
reason
consid
wide
spread
inflammatori
cell
even
physiolog
condit
without
viru
infect
actual
varieti
inflamm
factor
whose
product
secret
regul
calpain
report
elsewher
includ
combin
report
paper
could
conclud
calpain
particip
regul
wide
spectrum
inflamm
factor
product
research
peng
lab
anim
model
sepsi
myocardi
infarct
demonstr
respect
calpain
induc
myocardi
activ
might
explain
mechan
calpain
regul
inflamm
factor
product
data
anoth
group
lab
also
found
role
calpain
regul
activ
myocard
mice
unpublish
data
inflamm
factor
alway
fibrot
agent
solid
evid
calpain
involv
tissu
fibrosi
might
cystic
fibrosi
patient
jiang
et
al
report
regul
activ
vascular
smooth
muscl
cell
facilit
ageassoci
aortic
wall
fibrosi
observ
effect
calpain
myocardium
fibrosi
mention
pathway
inhibit
transgen
mous
indic
role
calpain
regul
classic
fibrosi
pathway
coincid
peng
lab
demonstr
calpain
inhibit
amelior
myocardi
remodel
myocardi
infarct
myocardi
fibrosi
diabet
cardiomyopathi
also
observ
role
calpain
regul
fibroblast
migrat
vitro
found
calpain
inhibit
hinder
fibroblast
migrat
scratch
assay
might
explain
novel
angl
mechan
calpain
mediat
fibrosi
studi
also
anim
studi
result
interpret
caution
clinic
practic
data
vmc
patient
collect
futur
clinic
studi
data
mainli
observ
mechan
studi
includ
role
calpain
replic
mediat
inflamm
vivo
perform
studi
respect
summari
myocard
model
present
calpain
play
dual
role
facilit
replic
mediat
inflammationfibrosi
endogen
inhibit
calpain
activ
show
signific
treatment
effect
myocard
might
provid
novel
target
viral
myocard
treatment
futur
declar
conflict
interest
